Annual EPS
-$17.35
+$12.13+41.15%
31 December 2023
Summary:
Kala Pharmaceuticals annual earnings per share is currently -$17.35, with the most recent change of +$12.13 (+41.15%) on 31 December 2023. During the last 3 years, it has risen by +$82.15 (+82.56%). KALA annual EPS is now at all-time high.KALA EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$1.93
+$1.23+38.92%
30 September 2024
Summary:
Kala Pharmaceuticals quarterly earnings per share is currently -$1.93, with the most recent change of +$1.23 (+38.92%) on 30 September 2024. Over the past year, it has increased by +$1.48 (+43.40%). KALA quarterly EPS is now -110.03% below its all-time high of $19.25, reached on 30 September 2022.KALA Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$12.47
+$1.48+10.61%
30 September 2024
Summary:
Kala Pharmaceuticals TTM earnings per share is currently -$12.47, with the most recent change of +$1.48 (+10.61%) on 30 September 2024. Over the past year, it has increased by +$10.26 (+45.14%). KALA TTM EPS is now -17714.29% below its all-time high of -$0.07, reached on 30 June 2023.KALA TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KALA EPS Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +41.1% | +43.4% | +45.1% |
3 y3 years | +82.6% | +91.0% | +87.8% |
5 y5 years | +86.1% | +94.3% | +91.4% |
KALA EPS High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +84.0% | -110.0% | +94.4% | <-9999.0% | +88.5% |
5 y | 5 years | at high | +87.4% | -110.0% | +94.4% | <-9999.0% | +91.4% |
alltime | all time | at high | +90.7% | -110.0% | +94.9% | <-9999.0% | +91.4% |
Kala Pharmaceuticals EPS History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$1.93(-38.9%) | -$12.47(-10.6%) |
June 2024 | - | -$3.16(-24.8%) | -$13.95(-7.9%) |
Mar 2024 | - | -$4.20(+32.1%) | -$15.15(-15.6%) |
Dec 2023 | -$17.35(-41.1%) | -$3.18(-6.7%) | -$17.94(-21.1%) |
Sept 2023 | - | -$3.41(-21.8%) | -$22.73(>+9900.0%) |
June 2023 | - | -$4.36(-37.6%) | -$0.07(-99.5%) |
Mar 2023 | - | -$6.99(-12.3%) | -$14.63(-50.9%) |
Dec 2022 | -$29.48(-72.8%) | -$7.97(-141.4%) | -$29.82(-47.1%) |
Sept 2022 | - | $19.25(-201.7%) | -$56.37(-41.9%) |
June 2022 | - | -$18.92(-14.7%) | -$97.03(-9.0%) |
Mar 2022 | - | -$22.18(-35.7%) | -$106.61(-2.1%) |
Dec 2021 | -$108.32(+8.9%) | -$34.52(+61.2%) | -$108.93(+6.9%) |
Sept 2021 | - | -$21.41(-24.9%) | -$101.91(-3.4%) |
June 2021 | - | -$28.50(+16.3%) | -$105.50(+7.7%) |
Mar 2021 | - | -$24.50(-10.9%) | -$98.00(-2.5%) |
Dec 2020 | -$99.50 | -$27.50(+10.0%) | -$100.50(-3.8%) |
Sept 2020 | - | -$25.00(+19.0%) | -$104.50(-7.9%) |
June 2020 | - | -$21.00(-22.2%) | -$113.50(-11.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2020 | - | -$27.00(-14.3%) | -$127.50(-7.6%) |
Dec 2019 | -$138.00(+10.8%) | -$31.50(-7.4%) | -$138.00(-4.5%) |
Sept 2019 | - | -$34.00(-2.9%) | -$144.50(+1.8%) |
June 2019 | - | -$35.00(-6.7%) | -$142.00(+3.6%) |
Mar 2019 | - | -$37.50(-1.3%) | -$137.00(+11.8%) |
Dec 2018 | -$124.50(-32.9%) | -$38.00(+20.6%) | -$122.50(+14.0%) |
Sept 2018 | - | -$31.50(+5.0%) | -$107.50(+3.4%) |
June 2018 | - | -$30.00(+30.4%) | -$104.00(+6.6%) |
Mar 2018 | - | -$23.00(0.0%) | -$97.59(-5.1%) |
Dec 2017 | -$185.50(+93.3%) | -$23.00(-17.9%) | -$102.82(-1.2%) |
Sept 2017 | - | -$28.00(+18.7%) | -$104.11(+0.0%) |
June 2017 | - | -$23.59(-16.4%) | -$104.08(-4.5%) |
Mar 2017 | - | -$28.23(+16.2%) | -$108.99(+13.6%) |
Dec 2016 | -$95.95(+98.8%) | -$24.29(-13.2%) | -$95.95(+33.9%) |
Sept 2016 | - | -$27.97(-1.9%) | -$71.66(+64.0%) |
June 2016 | - | -$28.50(+87.6%) | -$43.70(+187.6%) |
Mar 2016 | - | -$15.19 | -$15.19 |
Dec 2015 | -$48.26 | - | - |
FAQ
- What is Kala Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals annual EPS year-on-year change?
- What is Kala Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals quarterly EPS year-on-year change?
- What is Kala Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for Kala Pharmaceuticals?
- What is Kala Pharmaceuticals TTM EPS year-on-year change?
What is Kala Pharmaceuticals annual earnings per share?
The current annual EPS of KALA is -$17.35
What is the all time high annual EPS for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high annual earnings per share is -$17.35
What is Kala Pharmaceuticals annual EPS year-on-year change?
Over the past year, KALA annual earnings per share has changed by +$12.13 (+41.15%)
What is Kala Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of KALA is -$1.93
What is the all time high quarterly EPS for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high quarterly earnings per share is $19.25
What is Kala Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, KALA quarterly earnings per share has changed by +$1.48 (+43.40%)
What is Kala Pharmaceuticals TTM earnings per share?
The current TTM EPS of KALA is -$12.47
What is the all time high TTM EPS for Kala Pharmaceuticals?
Kala Pharmaceuticals all-time high TTM earnings per share is -$0.07
What is Kala Pharmaceuticals TTM EPS year-on-year change?
Over the past year, KALA TTM earnings per share has changed by +$10.26 (+45.14%)